Multi-rAb™ HRP-Goat Anti-Mouse Recombinant Secondary Antibody (H+L)
Multi-rAb™ Goat Anti-Mouse Recombinant Secondary Antibody (H+L) is a mixture of precisely engineered recombinant monoclonal antibodies that recognize multiple complementary epitopes on the mouse IgG heavy and light chains.
Cat no : RGAM001
Validation Data Gallery
Product Information
RGAM001 targets Mouse IgG (H+L) in ELISA and Western blot. It can bind to all mouse IgG isotypes, mouse IgM and IgA as well as rat IgG. It shows minimal reactivity for rabbit, human, pig and bovine IgGs.
| Concentration | 1.0 mg/mL |
| Applications | ELISA, WB, Dot blot |
| Host Species | Goat |
| Species Reactivity | Mouse |
| Physical State | Liquid |
| Suggested Dilution Range | 1:10,000-1:100,000 for ELISA 1:10,000-1:200,000 for western blotting with ECL substrates (1:10,000-1:40,000 is suggested for most systems). |
| Purity | |
| Storage Buffer | PBS with 50% glycerol, 10 mg/mL BSA, 0.1% Proclin-300, pH 7.4. |
| Storage Instructions | Store at -20°C. Stable for one year after shipment. |
| Clonality | Multiclonal recombinant |
| RRID | AB_3068333 |
| Note | This product is for research use only,not for diagnostic or therapeutic use. |
Background
Multi-rAb™ Recombinant Secondary Antibodies are mixtures of precisely engineered recombinant monoclonal antibodies that recognize multiple complementary epitopes on the same IgG. Each recombinant clone in the final multiclonal mixture is carefully selected after rigorous characterization and screening to ensure the highest level of performance. The selected clones are mixed in various combinations, each of which is then functionally characterized in multiple applications to select the final multiclonal mixture with optimal performance.
Each lot of Multi-rAb™ Secondary Antibodies is produced by mixing the same high performing recombinant clones every time to ensure that they have high batch-to-batch consistency, which in turn results in high reproducibility of experimental data.
Publications
| Title |
|---|
Drug Resist Updat Lansoprazole (LPZ) reverses multidrug resistance (MDR) in cancer through impeding ATP-binding cassette (ABC) transporter-mediated chemotherapeutic drug efflux and lysosomal sequestration |
J Extracell Vesicles Optimized AF4 combined with density cushion ultracentrifugation enables profiling of high-purity human blood extracellular vesicles |
Small Temperature-Sensitive Polymer-Driven Nanomotors for Enhanced Tumor Penetration and Photothermal Therapy |
EMBO Mol Med Luteolin detoxifies DEHP and prevents liver injury by degrading Uroc1 protein in mice |
ACS Appl Mater Interfaces Near-Infrared Stimuli-Responsive Hydrogel Promotes Cell Migration for Accelerated Diabetic Wound Healing |
Antiviral Res Kaempferide enhances type I interferon signaling as a novel broad-spectrum antiviral agent |